BlueCrow Capital

BlueCrow Capital is a venture capital firm established in 2010 and headquartered in Lisboa, Portugal. The firm focuses on investing in a diverse range of sectors, including robotics and information and communications technology (ICT), medical technology (medtech), biotechnology, sustainable food, laser technology, industrial applications, and agriculture. BlueCrow Capital aims to support innovative companies that are poised for growth and contribute to advancements in these key industries.

António Mello Campello

Co-Founder and Partner

Bernardo Meira

Co-Founder and Partner

Duarte Menezes

Partner and Fund Manager

10 past transactions

Bighub

Seed Round in 2025
Bighub is a marketplace integration technology and sales accelerator that synchronizes with over 30 marketplaces in a single ecosystem.

Sensei

Series A in 2024
Sensei Tech is a company that specializes in developing AI-powered video recognition systems designed to enhance the retail environment. Founded in 2017 and based in Lisbon, Portugal, Sensei transforms traditional video surveillance cameras into advanced sensors capable of analyzing in-store activities. By employing sophisticated algorithms and integrating computer vision with artificial intelligence, the company enables retailers to digitize their physical spaces and gain valuable insights into customer behavior and product performance. This technology provides retailers with real-time analytics on traffic flow, inventory management, and operational efficiency, fostering a frictionless shopping experience. Sensei's innovative solutions aim to facilitate the transition to autonomous, cash-free stores, thereby reshaping the future of retail.

Maven Pet

Pre Seed Round in 2024
Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Oceano Fresco

Venture Round in 2024
Oceano Fresco S.A., based in Mira, Portugal, specializes in the development and production of bivalve varieties aimed at enhancing the performance of shellfish farmers. Founded in 2015, the company employs a multi-disciplinary approach that incorporates molecular biology, genetics, and animal physiology to identify and cultivate beneficial traits in bivalves. Oceano Fresco focuses on sustainability and consumer safety, ensuring that its products are both environmentally friendly and economically viable for aquaculture. By collaborating with hatcheries, nurseries, and research institutions, the company tests and tailors its solutions to meet the specific requirements of its clients across various technical and environmental contexts. Through its vertically integrated operations and selective breeding programs, Oceano Fresco contributes to the production of healthy and flavorful seafood.

Tonic App

Series A in 2024
Tonic App S.A. is a technology company based in Porto, Portugal, that has developed a mobile application designed to enhance communication and collaboration among medical professionals. The application supports doctors by enabling messaging, sharing, and archiving of patient cases, as well as facilitating expert consultations and networking opportunities. It serves various stakeholders in the healthcare sector, including hospitals, pharmaceutical companies, and medical associations, to connect medical doctors with their peers and relevant communities. Additionally, the application provides access to essential medical content, allows for the coordination of urgent procedures, and enables discussions on clinical cases. With features like video consultations, prescription tools, and clinical decision support resources, Tonic App aims to improve the efficiency of clinical practices and ultimately enhance patient outcomes. Established in 2016, the company is recognized for its commitment to quality and safety in its clinical algorithms.

KIT-AR

Seed Round in 2024
KIT-AR Ltd is a company based in London, United Kingdom, that specializes in designing and developing integrated industrial augmented reality systems aimed at enhancing manufacturing productivity across various industries, including automotive, aerospace, and electronics. Founded in 2018, KIT-AR focuses on providing solutions that help reduce production errors and improve quality assurance on the shop floor. The company's offerings include KIT-ASSIST, which delivers specialist knowledge through a heads-up display; KIT-SMART, a set of intelligent modules that monitor the working environment and worker activity; KIT-BUILD, which manages work instructions; and KIT-INSIGHT, which provides insights into productivity and efficiency. By connecting and empowering shop floor employees with timely information and automated quality checks, KIT-AR enables manufacturers to minimize unplanned downtime and achieve higher accuracy in their operations.

Paynest

Seed Round in 2023
Paynest is a technology company that simplifies employee finance management. It offers an integrated platform with services such as expense management, on-demand compensation, and financial coaching, aiming to enhance employees' financial well-being and streamline daily operations for businesses. The company's mission is to reshape how companies engage with their employees, providing flexible and innovative solutions that allow both parties to focus on their core strengths.

PayNest

Seed Round in 2023
PayNest is a payments amalgamator, which was created with the core mission of digitizing cash collection in the Middle East.

Ophiomics

Series A in 2023
Ophiomics S.A. is a clinical-stage biotech company based in Lisbon, Portugal, specializing in the development of diagnostic products and services for liver cancer. Established in 2015, Ophiomics focuses on integrating bioinformatics, artificial intelligence, and genomics to enhance diagnostic and prognostic capabilities in oncology. The company is ISO 13485 and ISO 9001 certified, ensuring adherence to high-quality standards in its operations. Its product pipeline encompasses various stages of development, including pre-clinical programs and those undergoing clinical validation. Ophiomics aims to improve early detection of liver cancer through biomarker-based diagnostic devices that combine molecular signatures with clinical parameters in predictive algorithms, ultimately assisting healthcare providers in treatment selection and clinical follow-up for better patient outcomes.

Oceano Fresco

Venture Round in 2019
Oceano Fresco S.A., based in Mira, Portugal, specializes in the development and production of bivalve varieties aimed at enhancing the performance of shellfish farmers. Founded in 2015, the company employs a multi-disciplinary approach that incorporates molecular biology, genetics, and animal physiology to identify and cultivate beneficial traits in bivalves. Oceano Fresco focuses on sustainability and consumer safety, ensuring that its products are both environmentally friendly and economically viable for aquaculture. By collaborating with hatcheries, nurseries, and research institutions, the company tests and tailors its solutions to meet the specific requirements of its clients across various technical and environmental contexts. Through its vertically integrated operations and selective breeding programs, Oceano Fresco contributes to the production of healthy and flavorful seafood.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.